DEVELOPMENT AND INTERNAL VALIDATION OF A NOMOGRAM PREDICTING PROSTATE CANCER SPECIFIC SURVIVAL IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY AT A SINGLE EUROPEAN INSTITUTION